Comparison of safety and efficacy of treatment between transurethral plasma enucleation of the prostate and plasma kinetic resection of the prostate in patients with high-risk benign prostatic hyperplasia Liu Qingyong, Department of Urology, Thousand Buddha Mountain Hospital, Shandong Province Liu Qingyong, Department of Surgery, Thousand Buddha Mountain Hospital, Shandong Province, China Urological Surgery of the First Subjects: to discuss the comparison of the treatment of high-risk benign prostatic hyperplasia with transurethral enucleative resection of the prostate (TUERP) and transurethral bipolar plasma kinetic resection of the prostate (TKRP), and to compare with TKRP. TUERP) and transurethral bipolar plasma kinetic resection of the prostate (TKRP) for the treatment of high-risk prostatic hyperplasia (Benign prostatic hyperplasia, BPH) in terms of safety and efficacy. METHODS: We retrospectively analyzed 103 patients with high-risk BPH, and compared the weight of prostatectomy, intraoperative bleeding, operative time, postoperative continuous bladder irrigation time, indwelling catheter time, operative complications, and postoperative hospitalization time of the two surgical procedures; meanwhile, we also analyzed the preoperative and postoperative International Prostate Symptom Score (IPSS), quality of life (QOL), maximal urinary flow rate (Qmax), residual urine flow rate (RFR) and residual urination (URF) of the two groups. Qmax), and residual urine volume (PVR) were compared. RESULTS: 56 cases of TUERP and 47 cases of TKRP were performed. There was no statistically significant difference in the general conditions of the patients in the 2 groups before surgery (p>0.05); the differences in the IPSS, QOL, Qmax, and RVR of the patients in the groups after surgery were statistically significant when compared with the preoperative period (p<0.01), but the differences were not statistically significant in the comparison of all groups (p>0.05). The operation time (52.1±13.6/72.1±18.3) min, intraoperative bleeding (89.7±26.6/163.5±40.7) ml, postoperative bladder irrigation time (28.2±4.2/72.3±8.6) h, and postoperative hospitalization time (6.7±1.8/8.5±2.4) d were significantly smaller in the TUERP group than in the TKRP group (p <0.05), and the prostatectomy rate (48.1±15.3/32.4±17.7)g was significantly higher in the TUERP group than in the TKRP group (P<0.05). CONCLUSION: There is no statistically significant difference between the efficacy of TUERP and TKRP in the treatment of high-risk BPH. TUERP has shorter operation time, postoperative bladder irrigation time and hospitalization time, less intraoperative bleeding and fewer complications.TUERP is an ideal method for the treatment of prostatic hyperplasia.